Exploring Foundation Medicine Roche

Exploring Foundation Medicine Roche reveals several interesting facts.

  • At
  • Our Research and Development team is constantly pushing the envelope to transform cancer care. Through interdisciplinary ...
  • This video walks through the basic steps of using liquid biopsy* for comprehensive genomic profiling. *FoundationOne®Liquid ...
  • In this webinar, hear about updates to the current treatment landscape for hormone-receptor positive, HER2-negative metastatic ...
  • Foundation Medicine - Roche

In-Depth Information on Foundation Medicine Roche

Learn about our comprehensive and validated approach to reveal the genomic drivers of a patient's cancer so doctors can help ... In this special episode of OncoInfluencers, hosted by Dr. Gevorg Tamamyan, we are honored to welcome Dr. Levi Garraway, one ... Foundation Andre Goy, MD, from John Theurer Cancer Center at Hackensack University

Foundation

Stay tuned for more updates related to Foundation Medicine Roche.

Recent Articles

The Foundation Medicine Approach to Personalized Cancer Treatment

The Foundation Medicine Approach to Personalized Cancer Treatment

Learn about our comprehensive and validated approach to reveal the genomic drivers of a patient's cancer so doctors can help ...

June 11, 2026
Roche’s CMO Levi Garraway on Personal Journey, Developing Foundation Medicine, and Cancer Research

Roche’s CMO Levi Garraway on Personal Journey, Developing Foundation Medicine, and Cancer Research

In this special episode of OncoInfluencers, hosted by Dr. Gevorg Tamamyan, we are honored to welcome Dr. Levi Garraway, one ...

June 11, 2026
Foundation Frontiers Comprehensive Genomic Profiling Education - Mini-Molecular Tumor Board

Foundation Frontiers Comprehensive Genomic Profiling Education - Mini-Molecular Tumor Board

Foundation

June 11, 2026
Goy Discusses Impact of Roche/Foundation Medicine Partnership on Diagnostics Tech

Goy Discusses Impact of Roche/Foundation Medicine Partnership on Diagnostics Tech

Andre Goy, MD, from John Theurer Cancer Center at Hackensack University

June 11, 2026
PROUD at Foundation Medicine

PROUD at Foundation Medicine

At

June 11, 2026
Working at Foundation Medicine: Research and Development Team

Working at Foundation Medicine: Research and Development Team

Our Research and Development team is constantly pushing the envelope to transform cancer care. Through interdisciplinary ...

June 11, 2026
Foundation Frontiers: Case-based Liquid Biopsy Education - Introduction to Liquid Biopsy

Foundation Frontiers: Case-based Liquid Biopsy Education - Introduction to Liquid Biopsy

This video walks through the basic steps of using liquid biopsy* for comprehensive genomic profiling. *FoundationOne®Liquid ...

June 11, 2026
Foundation Frontiers: Advanced Breast Cancer - Updates to HR+/HER2- Treatment Landscape

Foundation Frontiers: Advanced Breast Cancer - Updates to HR+/HER2- Treatment Landscape

In this webinar, hear about updates to the current treatment landscape for hormone-receptor positive, HER2-negative metastatic ...

June 11, 2026
Foundation Medicine - Roche

Foundation Medicine - Roche

Foundation Medicine - Roche

June 11, 2026
Foundation Frontiers Case-based Comprehensive Genomic Profiling Education - CGP for Fusion Detection

Foundation Frontiers Case-based Comprehensive Genomic Profiling Education - CGP for Fusion Detection

Foundation

June 11, 2026
Foundation Medicine CEO Dr. Brian Alexander on Foundation Medicine's partnership on the TRACK study.

Foundation Medicine CEO Dr. Brian Alexander on Foundation Medicine's partnership on the TRACK study.

Dr. Brian Alexander, CEO of

June 11, 2026
Labiotech Tour Boston 2015: Foundation Medicine  with Medical Director, Jeffrey Ross

Labiotech Tour Boston 2015: Foundation Medicine with Medical Director, Jeffrey Ross

[REUPLOADING] In our second documentary in Boston, the largest biotech ecosystem in the world, we visited

June 11, 2026
Diversity in clinical trials: Why including every eligible patient matters

Diversity in clinical trials: Why including every eligible patient matters

It's no longer about why we need to ensure representative patient populations in clinical trials. It's more about how we do so.

June 11, 2026